热门出版物 - 学术资源搜索

h5 指数:81
h5 中位数:110

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#5 Cardiology

标题/作者	引用次数	年份
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ... European Journal of Heart Failure 18 (8), 891-975	10052	2016
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) JL Zamorano, P Lancellotti, D Rodriguez Muñoz, V Aboyans, ... European Journal of Heart Failure 19 (1), 9-42	1063	2017
Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology AR Lyon, E Bossone, B Schneider, U Sechtem, R Citro, SR Underwood, ... European Journal of Heart Failure 18 (1), 8-27	561	2016
Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine A Mebazaa, MB Yilmaz, P Levy, P Ponikowski, WF Peacock, S Laribi, ... European Journal of Heart Failure 17 (6), 544-558	387	2015
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review EES van Riet, AW Hoes, KP Wagenaar, A Limburg, MAJ Landman, ... European Journal of Heart Failure 18 (3), 242-252	319	2016
Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology VP Harjola, A Mebazaa, J Čelutkienė, D Bettex, H Bueno, O Chioncel, ... European Journal of Heart Failure 18 (3), 226-241	267	2016
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions MG Crespo‐Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... European Journal of Heart Failure 18 (6), 613-625	257	2016
Clinical picture and risk prediction of short‐term mortality in cardiogenic shock VP Harjola, J Lassus, A Sionis, L Køber, T Tarvasmäki, J Spinar, ... European Journal of Heart Failure 17 (5), 501-509	245	2015
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry O Chioncel, M Lainscak, PM Seferovic, SD Anker, MG Crespo‐Leiro, ... European Journal of Heart Failure 19 (12), 1574-1585	232	2017
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ... European Journal of Heart Failure 20 (5), 853-872	197	2018
Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials EA Jankowska, M Tkaczyszyn, T Suchocki, M Drozd, S von Haehling, ... European Journal of Heart Failure 18 (7), 786-795	194	2016
Concomitant implantation of Impella® on top of veno‐arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock F Pappalardo, C Schulte, M Pieri, B Schrage, R Contri, G Soeffker, ... European Journal of Heart Failure 19 (3), 404-412	179	2017
Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double‐blind, randomised, placebo‐controlled trial A Jorsal, C Kistorp, P Holmager, RS Tougaard, R Nielsen, A Hänselmann, ... European Journal of Heart Failure 19 (1), 69-77	177	2017
Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation JM ter Maaten, K Damman, MC Verhaar, WJ Paulus, DJ Duncker, ... European Journal of Heart Failure 18 (6), 588-598	153	2016
Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study K Tsuji, Y Sakata, K Nochioka, M Miura, T Yamauchi, T Onose, R Abe, ... European Journal of Heart Failure 19 (10), 1258-1269	152	2017
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis SD Anker, BA Kirwan, DJ van Veldhuisen, G Filippatos, J Comin‐Colet, ... European Journal of Heart Failure 20 (1), 125-133	146	2018
MicroRNAs in heart failure: from biomarker to target for therapy EL Vegter, P van der Meer, LJ de Windt, YM Pinto, AA Voors European Journal of Heart Failure 18 (5), 457-468	143	2016
Heart failure as a general pandemic in Asia H Shimokawa, M Miura, K Nochioka, Y Sakata European Journal of Heart Failure 17 (9), 884-892	139	2015
Prevalence and prognostic impact of frailty and its components in non‐dependent elderly patients with heart failure MT Vidán, V Blaya‐Novakova, E Sánchez, J Ortiz, JA Serra‐Rexach, ... European Journal of Heart Failure 18 (7), 869-875	137	2016
Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure S Coiro, P Rossignol, G Ambrosio, E Carluccio, G Alunni, A Murrone, ... European Journal of Heart Failure 17 (11), 1172-1181	134	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。